FDA Resolves Semaglutide Shortage, Warns Against Compounders
The US Food and Drug Administration (FDA) announced that it has resolved a shortage of semaglutide injection products, including Novo Nordisk’s Ozempic and Wegovy. This development comes as shares of Hims & Hers Health plummeted 26% after the FDA warned that it will take action against compounders who produce custom-made alternatives to brand-name drugs. Semaglutide … Read more